Daratumumab Combined with Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis Patients with Translocation (11;14): a Multicenter Phase 2 Study
Latest Information Update: 11 Oct 2024
At a glance
- Drugs Daratumumab (Primary) ; Daratumumab (Primary) ; Dexamethasone (Primary) ; Venetoclax (Primary)
- Indications Amyloid light-chain amyloidosis
- Focus Therapeutic Use
- 11 Oct 2024 New trial record